Pharma Focus America

LATEST NEWSRead more...

24

Jul 2024

Orange Grove Bio and the University of Chicago Collaborate to Drive Innovation and Commercialization in Biotechnology

Orange Grove Bio a leading biopharmaceutical company has teamed up with the University of Chicagos Polsky Center for Entrepreneurship and Innovation to drive the commercialization

24

Jul 2024

Frontier Medicines Receives Milestone Payment from AbbVie After Advancing Lead Candidates Aimed at Challenging Transcription Factor

Frontier Medicines Corporation a clinicalstage company dedicated to advancing precision medicine by targeting challenging diseaserelated proteins has made significant progress in its collaboration

24

Jul 2024

Enterprise Therapeutics Begins Phase 2 Trial of ETD001 with First Cystic Fibrosis Patient Dosed

Enterprise Therapeutics Ltd a biopharmaceutical firm focused on creating novel treatments for respiratory diseases has announced the start of dosing in its Phase a trial for ETD a new therapy for cystic fibrosis

24

Jul 2024

Alcami Introduces Upgraded Conditions and Services at Advanced Pharmaceutical Storage Facility in Garner

Alcami Corporation a leading CDMO has expanded its capabilities with a new squarefoot pharmaceutical storage facility in Garner North Carolina Located near the Research Triangle Park

24

Jul 2024

FDA Grants RMAT Designation to AffyImmune's AIC100 for Treatment of Recurrent Anaplastic Thyroid Cancer

AffyImmune a biotechnology company specializing in innovative chimeric antigen receptor CAR Tcell therapies has announced that its CAR Tcell product AIC has been granted Regenerative Medicine

23

Jul 2024

Avenacy Introduces Palonosetron Hydrochloride Injection, USP to the U.S. Market

Avenacy a specialty pharmaceutical company dedicated to critical injectable medications has introduced Palonosetron Hydrochloride Injection USP in the US This new product serves as a generic version of Aloxi and has received approval from the US Food and Drug Administration

press releasesRead more...

Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants

Merck known as MSD outside of the United States and Canada today announced positive topline results from its Phase b clinical trial evaluating clesrovimab

Vividion Therapeutics to Expand with New Global Research and Development Center

Vividion Therapeutics Inc a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock highvalue traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders

UniQure Announces Closing of Sale of Manufacturing Facility to Genezen

UniQure NV a leading gene therapy company advancing transformative therapies for patients with severe medical needs today announced the closing of the sale of its global manufacturing facility in Lexington Massachusetts to Genezen

Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in Canada

Today Emergent BioSolutions announced the shelflife extension for NARCAN Nasal Spray from three years to four years to all newly manufactured product The update makes NARCAN Nasal Spray the only mg intranasal naloxone spray in Canada

29 - 31

Jul 2024

29 - 31

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

15 - 16

Aug 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

20 - 22

Aug 2024
Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific - mRNA Services
Future Labs Live USA 2024
World Vaccine Congress Europe 2024
World Orphan Drug Congress 2024
Advanced Therapies USA 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 1

    The Role of mRNA Technology Beyond COVID-19 Vaccines: A New Era in Medicine

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 2

    Data Analytics and Forecasting in Pharmaceutical Distribution

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    Addressing the Opioid Crisis: The Role of Pharmaceutical Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    The Future of Pharma: Integrating Imaging Informatics for Better Outcomes

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues